Anúncio
Anúncio
ENTA
Enanta Pharmaceuticals, Inc
13.13
USDPatrocinado
-0.31
-2.31%
09 de jan., 15:59 UTC -5
Encerrado
Pós-Mercado
13.54
+0.40
+3.08%
Relatórios de Lucros ENTA
Rácio de surpresa positiva
ENTA separação 25 de 39 últimas estimativas.
64%
Próximo Relatório
Data do Próximo Relatório
09 de fev. de 2026
Estimate for Q1 26 (Revenue/ EPS)
$16.46M
/-$0.82
Mudanças implicadas de Q4 25 (Revenue/ EPS)
+8.84%
/-5.75%
Mudanças implicadas de Q1 25 (Revenue/ EPS)
-2.93%
/-21.90%
Enanta Pharmaceuticals, Inc earnings per share and revenue
On 17 de nov. de 2025, ENTA reported earnings of -0.87 USD per share (EPS) for Q4 25, beating the estimate of -1.04 USD, resulting in a 16.46% surprise. Revenue reached 15.13 milhão, compared to an expected 16.28 milhão, with a -7.07% difference. The market reacted with a -3.59% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 6 analistas forecast an EPS of -0.82 USD, with revenue projected to reach 16.46 milhão USD, implying an diminuir of -5.75% EPS, and aumentar of 8.84% in Revenue from the last quarter.
FAQ
What were Enanta Pharmaceuticals, Inc's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Enanta Pharmaceuticals, Inc reported EPS of -$0.87, beating estimates by 16.46%, and revenue of $15.13M, -7.07% below expectations.
How did the market react to Enanta Pharmaceuticals, Inc's Q4 2025 earnings?
The stock price moved down -3.59%, changed from $12.82 before the earnings release to $12.36 the day after.
When is Enanta Pharmaceuticals, Inc expected to report next?
The next earning report is scheduled for 09 de fev. de 2026.
What are the forecasts for Enanta Pharmaceuticals, Inc's next earnings report?
Based on 6
analistas, Enanta Pharmaceuticals, Inc is expected to report EPS of -$0.82 and revenue of $16.46M for Q1 2026.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio